Medline Inc. plans to list on the Nasdaq Global Select Market under the symbol MDLN, at $26.00 to $30.00 a share. It filed a Form S-1 registration statement for an initial public offering on October 28, 2025. As of November 8, 2026, its final prospectus is on file (Form 424B4, May 26, 2026).
Sell to companies like Medline Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Key facts
- · What it is: Final prospectus filed: the offering is priced · 424B4
- · What it is: Registration statement filed · S-1
- · What it is: Final prospectus filed: the offering is priced · 424B4
- · What it is: Registration statement filed · S-1
- · What it is: Final prospectus filed: the offering is priced · 424B4
Medline Inc. filed a Form S-1 registration statement for an initial public offering on 2025-10-28. It has amended it 2 times. It filed its final prospectus on 2026-05-26. Each fact below is quoted from the filing named with it.
Also on the record for Medline Inc.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| November 6, 2026 | Stake report, Schedule 13G/A, by GIC Private Limited | 8.49% of the class | 5%+ stakes | Source |
| October 30, 2026 | Stake report, Schedule 13G/A, by GIC Private Limited | 13.03% of the class | 5%+ stakes | Source |
| October 15, 2026 | Leadership change: Joseph P. Baratta departs | — | Leadership changes | Source |
| August 11, 2026 | Stake report, Schedule 13G/A, by Hellman & Friedman Investors X, L.P. | 16% of the class | 5%+ stakes | Source |
| August 7, 2026 | Stake report, Schedule 13G/A, by BMA VIII L.L.C. | 16.5% of the class | 5%+ stakes | Source |
| August 6, 2026 | Stake report, Schedule 13G, by FMR LLC | 5.5% of the class | 5%+ stakes | Source |
| July 9, 2026 | Leadership change filing (Form 8-K, Item 5.02) | — | Leadership changes | Source |
| May 15, 2026 | Stake report, Schedule 13G/A, by Carlyle Group Inc. | 20.6% of the class | 5%+ stakes | Source |
| May 7, 2026 | Stake report, Schedule 13G/A, by Abu Dhabi Investment Authority | 4.9% of the class | 5%+ stakes | Source |
| May 6, 2026 | Stake report, Schedule 13G/A, by Hellman & Friedman Investors X, L.P. | 19.8% of the class | 5%+ stakes | Source |
| May 1, 2026 | Stake report, Schedule 13G/A, by BMA VIII L.L.C. | 20.6% of the class | 5%+ stakes | Source |
| February 13, 2026 | Stake report, Schedule 13G, by BMA VIII L.L.C. | 24.4% of the class | 5%+ stakes | Source |
Check before you invest in Medline Inc.: the warning signs and who's behind it, free.
Free to see. No signup.
Keep reading
More on Medline Inc. and the records around it.
Medline Inc. elsewhere on the record
- 5%+ stake filings Nov 2026
- Leadership changes Jul 2026
- Who owns it
Companies that share a holder
- Abu Dhabi Investment Authority also filed stake reports on 7 other companies: Jersey Mike's Subs Inc. (Oct 2026), Eikon Therapeutics, Inc. (Oct 2026), AGL Private Credit Income Fund (Sep 2026)
- BX Mozart ML-2 Holdco L.P. also filed stake reports on 7 other companies: Corebridge Financial, Inc. (Nov 2026), Jersey Mike's Subs Inc. (Nov 2026), VARAGON CAPITAL CORPORATION (Oct 2026)
- Carlyle Group Inc. also filed stake reports on 7 other companies: SunPower Inc. (Aug 2026), Q32 Bio Inc. (Jul 2026), StandardAero, Inc. (May 2026)
Also filing to list on the Nasdaq Global Select Market
IPO filings on the Nasdaq Global Select Market in Q2 2026, newest first.
- Cardinal Infrastructure Group Inc. (Jun 2026)
- Pattern Group Inc. (Jun 2026)
- SOLV Energy, Inc. (May 2026)
- Cerebras Systems Inc. (May 2026)
- SUJA LIFE, INC. (May 2026)
Watch Medline Inc.
Get an email when Medline Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Medline Inc.?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Medline Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Medline Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
20 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
The newest 12 of 17 records.
What the filings say
Listing
Our shares of Class A common stock are listed on the Nasdaq Global Select Market (“Nasdaq”) under the trading symbol “MDLN.”From the 424B4 filed 2026-05-26
Shares offered
The selling stockholders are offering 75,000,000 shares of Medline Inc.’s Class A common stock in thisFrom the 424B4 filed 2026-03-06
Price range
We currently expect the initial public offering price to be between $26.00 and $30.00 per share of Class A common stock.From the S-1/A filed 2025-12-08
Net loss or income
For the three months ended March 28, 2026, we generated net sales of $7.4 billion, net income of $0.2 billion, and Adjusted EBITDA of $0.8 billion, representing a net income margin of 3.3% and an Adjusted EBITDA Margin of 10.6%.From the S-1 filed 2026-05-20
Timeline
| Filed | What it is | Filing |
|---|---|---|
| 2025-10-28 | Registration statement filed | S-1 |
| 2025-11-04 | Registration statement amended | S-1/A |
| 2025-12-08 | Registration statement amended | S-1/A |
| 2025-12-18 | Final prospectus filed: the offering is priced | 424B4 |
| 2026-03-03 | Registration statement filed | S-1 |
| 2026-03-06 | Final prospectus filed: the offering is priced | 424B4 |
| 2026-05-20 | Registration statement filed | S-1 |
| 2026-05-26 | Final prospectus filed: the offering is priced | 424B4 |
Tools for this story
Each opens in a new tab, filled in for Medline Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
A company that wants to sell shares to the public in the United States files a registration statement with the SEC: Form S-1 for a US company, Form F-1 for a foreign one. It amends that statement as the figures and terms are filled in, usually adding the expected price range shortly before the offering. Once the offering is priced it files its final prospectus under Rule 424(b)(4). A company that decides not to go ahead can ask for the registration statement to be withdrawn on Form RW.
Every row on this page is one of those filings, linked to the filing itself. The facts are the company's own sentences, quoted from the filing named beside each one and never reworded; where no filing states a fact in a sentence that can be read exactly, this page leaves it out. A filing is the company's statement of its plans and its figures, not a verification of them, and nothing here is investment advice.